Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Hims & Hers Health (HIMS) Long-Term Deferred Tax (2024 - 2025)

Hims & Hers Health (HIMS) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $82.7 million as the latest value for Q4 2025.

Quarterly Long-Term Deferred Tax rose 34.26% to $82.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82.7 million through Dec 2025, up 34.26% year-over-year, with the annual reading at $82.7 million for FY2025, 34.26% up from the prior year.
Long-Term Deferred Tax hit $82.7 million in Q4 2025 for Hims & Hers Health, down from $84.9 million in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $84.9 million in Q3 2025 to a low of $54.3 million in Q3 2024.